Ghaith Wedeh

发表

Identification of Bromodomain-Containing Protein 4 (BRD4) as a Novel Marker and Epigenetic Target in Systemic Mastocytosis and Mast Cell Leukemia

Ghaith Wedeh, 2016 .

Identification of bromodomain-containing protein 4 (BRD4) as a novel marker and epigenetic target in mast cell leukemia

J. Bradner, J. Zuber, A. Reiter, 2015, Leukemia.

SUMO1 depletion prevents lipid droplet accumulation and HCV replication

Ghaith Wedeh, A. Gassama-Diagne, Abdellah Akil, 2015, Archives of Virology.

In vitro and in vivo efficacy of an anti-CD203c conjugated antibody (AGS-16C3F) in mouse models of advanced systemic mastocytosis.

J. Launay, F. Doñate, M. Arock, 2019, Blood advances.

A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection.

T. Rülicke, P. Valent, P. Dubreuil, 2014, Blood.

MYELOID NEOPLASIA A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D 816 V transfection

T. Rülicke, P. Valent, P. Dubreuil, 2014 .

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis

P. Valent, D. Metcalfe, K. Gleixner, 2018, Haematologica.

A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase

J. Launay, T. Würdinger, M. Arock, 2016, Oncotarget.

SUMO1 depletion prevents lipid droplet accumulation and HCV replication

Ghaith Wedeh, A. Gassama-Diagne, Abdellah Akil, 2015, Archives of Virology.

Bromodomain-Containing Protein 4 (BRD4): A Novel Marker and Drug Target Expressed In Neoplastic Cells In Advanced Mast Cell Neoplasms

J. Bradner, J. Zuber, P. Valent, 2013 .